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Mutations in the 5* nontranslated RNA (5*NTR) of an attenuated, cell culture-adapted hepatitis A virus
(HAV), HM175/P16, enhance growth in cultured African green monkey kidney (BS-C-1) cells but not in fetal
rhesus monkey kidney (FRhK-4) cells (S. P. Day, P. Murphy, E. A. Brown, and S. M. Lemon, J. Virol. 66:
6533–6540, 1992). To determine whether these mutations enhance cap-independent translation directed by the
HAV internal ribosomal entry site (IRES), we compared the translational activities of the 5*NTRs of wild-type
and HM175/P16 viruses in two stably transformed cell lines (BT7-H and FRhK-T7) which constitutively
express cytoplasmic bacteriophage T7 RNA polymerase and which are derived from BS-C-1 and FRhK-4 cells,
respectively. Translational activity was assessed by monitoring expression of a reporter protein, chloramphen-
icol acetyltransferase (CAT), following transfection with plasmid DNAs containing bicistronic T7 transcrip-
tional units of the form luciferase-5*NTR-CAT. In both cell types, transcripts containing the 5*NTR of
HM175/P16 expressed CAT at levels that were 50- to 100-fold lower than transcripts containing the IRES
elements of Sabin type 1 poliovirus or encephalomyocarditis virus, confirming the low activity of the HAV
IRES. However, in BT7-H cells, transcripts containing the 5*NTR of HM175/P16 expressed CAT with four- to
fivefold greater efficiency than transcripts containing the 5*NTR of wild-type virus. This translational enhance-
ment was due to additive effects of a UU deletion at nucleotides 203 and 204 and a U-to-G substitution at
nucleotide 687 of HM175/P16. These mutations did not enhance translation in FRhK-T7 or Huh-T7 cells (a T7
polymerase-expressing cell line derived from human hepatoblastoma cells) or in vitro in rabbit reticulocyte
lysates. These results demonstrate that mutations in the 5*NTR of a cell culture-adapted HAV enhance viral
replication by facilitating cap-independent translation in a cell-type-specific fashion and support the concept
that picornaviral host range is determined in part by differences in cellular translation initiation factors.
Hepatitis A virus (HAV), a picornavirus classified within the
genus Hepatovirus, is a hepatotropic virus which is a common
cause of acute viral hepatitis in humans (28). Since the first
demonstration that HAV may be propagated in cell culture
(35), there have been many attempts to develop HAV vaccines.
Formalin-inactivated HAV vaccines that are both efficacious
and safe have been developed (22, 42). However, progress in
the development of attenuated vaccine candidates has been
considerably slower (39). In theory, an attenuated HAV vac-
cine could have an advantage over inactivated vaccines in
terms of cost, the potential for oral administration, and the
likelihood of providing long-term immunity following a single
dose. While adaptation of wild-type HAV to efficient growth in
African green monkey kidney cells has resulted in virus vari-
ants that are highly attenuated with respect to the ability to
cause acute hepatocellular injury in susceptible primates, these
cell culture-adapted HAVs replicate poorly in vivo and gener-
ally produce only low-level protective antibody responses (26,
31, 41). Furthermore, attenuated vaccine candidates which
have been selected in this manner appear to be incapable of
initiating infection by the oral route (40). Thus, recombinant
DNA technology offers an attractive alternative for the ratio-
nal design of improved attenuated vaccine candidates with
more desirable replication properties in vivo. Definition of the
molecular basis of attenuation associated with cell culture ad-
aptation of HAV represents an important step in this direction.
Complete cDNA copies of the genomes of two indepen-
dently isolated, attenuated cell culture-adapted variants of the
HM175 strain of HAV have been molecularly cloned, and their
sequences have been compared with that of their common
wild-type parent (HM175/wt) (9, 25). Both of these attenuated
viruses were adapted to grow in African green monkey kidney
cells. One virus, HM175/P16, which replicates very poorly in
primates compared with HM175/wt, contains 19 mutations
from the wild-type sequence which are scattered throughout
the 7.5-kb genome (25, 41). Seven of these mutations are found
as similar or identical mutations in a second cell culture-
adapted and attenuated HM175 strain variant, HM175/P35
(9). Although mutations in the P2 region (proteins 2B and 2C)
have been shown to be of primary importance in adaptation of
the virus to growth in cultured cells (14, 15), the presence of
shared mutations within the 59 nontranslated RNAs (59NTRs)
of these two independently isolated HM175 variants suggests
that these mutations may also be important for cell culture
adaptation (25). Previous studies with chimeric viruses rescued
from infectious cDNAs containing the 59NTR sequence of the
HM175/wt, HM175/P16, or HM175/P35 genome indicated that
several mutations in the 59NTR of HM175/P16 virus (at nucle-
otides [nt] 152 and/or 203 and 204 and at nt 687) significantly
enhance growth of the virus in cell culture (10, 11). Interest-
ingly, the enhancement in replication conferred by these mu-
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tations was present in cultured African green monkey kidney
(BS-C-1) cells but not in fetal rhesus kidney (FRhK-4) cells,
which are also permissive for HAV (11).
The 59NTR of HAV, like that of other picornaviruses, forms
a highly ordered secondary structure (Fig. 1) and contains
elements which are necessary for both viral translation and
RNA replication (1, 5, 6, 33, 37, 38). Picornavirus translation is
initiated in a cap-independent fashion by a mechanism that
involves the binding of the 40S ribosomal subunit at a site
located hundreds of bases downstream of the 59 end of the
RNA which has been termed a ribosomal landing pad or an
internal ribosomal entry site (IRES) (23, 34). Although the
details of translation initiation by internal entry are unknown,
it likely involves the interaction of a set of trans-acting cellular
translation initiation factors with the cis-acting IRES, resulting
in the binding of the 40S ribosomal subunit to the RNA. The
existence of an HAV IRES has been demonstrated by exper-
iments in which the 59NTR sequence was placed within the
intercistronic space of bicistronic RNAs, with the result that
the second cistron was translated independently of the first
cistron and in a manner dependent on the integrity of the
59NTR sequence both in vitro and in vivo (6, 20, 43). Muta-
tional analysis of the HAV 59NTR has shown that the IRES is
located downstream of nt 161 and extends to within 40 nt of the
first initiator AUG, which is located at nt 734 (6).
While analysis of HAV translation in vitro in rabbit reticu-
locyte lysates has been useful in defining the 59 and 39 limits of
the HAV IRES (6), the studies examining the impact of
59NTR mutations on viral replication which are described
above suggest that there may be cell-type-specific aspects to
viral translation that could be appreciated only in an in vivo
system (11). For this reason, we previously constructed an
HAV-permissive cell line (BT7-H), derived from cultured Af-
rican green monkey kidney (BS-C-1) cells, that constitutive-
ly expresses cytoplasmic bacteriophage T7 RNA polymerase
(43). Transfection of these cells with plasmid DNA containing
a T7 transcriptional unit results in efficient transcription of
uncapped, cytoplasmic RNA transcripts which are very poorly
translated if they do not contain an IRES (13, 43). We have
shown previously that the translation of uncapped monocis-
tronic and bicistronic T7 transcripts containing the reporter
gene chloramphenicol acetyltransferase (CAT) fused in frame
with the HAV 59NTR is very inefficient in the BT7-H cells (43).
It is likely that this low translational efficiency of the HAV
IRES contributes to the normally slow growth of HAV in
cultured cells.
Here, we describe experiments in which we examined the
effects of mutations which are present in the 59NTR of the cell
culture-adapted and attenuated HM175/P16 virus on cap-in-
dependent translation in cultured monkey kidney cells. We
established a second T7 RNA polymerase-expressing cell line
(FRhK-T7), derived from FRhK-4 cells, so that we could carry
out experiments in parallel in cells of adult African green
monkey kidney and fetal rhesus kidney lineage. We found that
the 59NTR mutations present in HM175/P16 virus enhanced
IRES-directed translation in BT7-H cells but not in FRhK-T7
cells, paralleling the cell-type-specific impact of these muta-
tions on viral replication (11). The mutations responsible for
this translational enhancement were the UU deletion at bases
203 and 204 and the U-to-G substitution at base 687. These
results thus demonstrate that mutations in the 59NTR of a cell
culture-adapted HAV enhance viral replication by facilitating
cap-independent translation in a cell-type-specific fashion and
add to our current understanding of the determinants of the
host range of HAV and other picornaviruses.
MATERIALS AND METHODS
Plasmids. Construction of the plasmids pHAV-CAT1, pEMCV-CAT, pLUC-
P16-CAT (formerly pLUC-HAV-CAT), and pLUC-D355-532-CAT has been
described previously (43). pLUC-EMCV-CAT and pLUC-SAB-CAT contain
bicistronic T7 transcriptional units in which an upstream firefly luciferase coding
region and a downstream CAT coding region are separated by either the en-
cephalomyocarditis virus (EMCV) IRES (nt 243 to 836) or the entire Sabin type
1 poliovirus 59NTR (nt 1 to 742) placed within the intercistronic space. pLUC-
EMCV-CAT was constructed by subcloning the 1.7-kb EcoRI-PstI fragment of
pCITE-1 (Novagen), containing the EMCV IRES, into the AccI-PstI sites of
pLUC-HAV-CAT, to create pCITE-LUC. To create pLUC-EMCV-CAT, the
4.3-kb ApaI-NotI fragment of pCITE-LUC was replaced with the 1.6-kb frag-
ment from pEMCV-CAT. pLUC-SAB-CAT was constructed by PCR amplifica-
tion of a 0.8-kb fragment containing the Sabin type 1 poliovirus 59NTR with
flanking HindIII and XbaI sites from pCAS7 (a generous gift from J. Almond,
University of Reading) with the sense primer 59-AGTGACCTAAGCTTAAAA
CAGCTCTGGGGTTCC-39 and the antisense primer 59-AAACCTGTCTAGA
CATTATGATACAATTGTCTG-39. The 0.75-kb HindIII-XbaI fragment of
pHAV-CAT1 containing the HAV 59NTR was then replaced with the 0.75-kb
HindIII-XbaI-digested PCR fragment containing the Sabin type 1 59NTR. The
resulting plasmid, pSAB-CAT, was digested with HindIII and NotI, and the
1.8-kb fragment was subcloned into the AccI-NotI sites of pLUC-P16-CAT to
create pLUC-SAB-CAT.
pLUC-WT-CAT contains a similar bicistronic T7 transcriptional unit contain-
ing the HM175/wt virus 59NTR in the intercistronic space. It was constructed by
replacing the 0.75-kbHindIII-XbaI fragment of pHAV-CAT1, containing the cell
culture-adapted HM175/P16 virus 59NTR, with the HindIII-XbaI fragment from
pA/7-59WT (11), containing the HM175/wt 59NTR, to create the monocistronic
plasmid pWT-CAT1. To create the bicistronic plasmid pLUC-WT-CAT, the
1.8-kb HindIII-NotI fragment from pLUC-P16-CAT was replaced with the cor-
responding HindIII-NotI fragment from pWT-CAT.
Plasmids p152, p203, p687, and p152.203.687 are identical to pLUC-WT-CAT
except that they contain individual mutations (A-to-G substitution at nt 152; TT
deletion at nt 203 and 204; T-to-G substitution at nt 687) which are present in the
cell culture-adapted HM175/P16 virus at the positions indicated. For the con-
struction of p152 and p203, mutations were introduced at nt 152 and nt 203 and
204 of the HM175/wt sequence by PCR mutagenesis. First, 0.17- and 0.22-kb
fragments containing the 39 end of the luciferase gene and part of the HAV
59NTR were PCR amplified from pLUC-WT-CAT with the sense primer 59-TA
AGTGTATTCAGCGATGAC-39 and either the 152 mutagenic primer 59-CTT
GTAAATATTGATTCCTGCAC-39 or the 203-204 mutagenic primer 59-AAGA
ACACTCATTTCACGCTTTC-39. An aliquot of these PCR products was then
used as a primer with the antisense primer 59-GTCAATCCACTCAATGCA
TC-39 to PCR amplify 0.6-kb fragments containing nt 1 to 545 of the HAV
HM175/wt 59NTR with either an A-to-G substitution at nt 152 or a TT deletion
at nt 203 and 204. These fragments were then digested with HindIII and HpaI,
and the resulting 0.35-kb fragments were subcloned into the HindIII-HpaI sites
of pLUC-WT-CAT to create p152 and p203. p152.203 was constructed by PCR
FIG. 1. Proposed secondary structure of the HM175/wt 59NTR (5, 37). Major
structural domains are labeled I through VI; the small open boxes indicate the
locations of the two initiator AUG codons, Met-1 andMet-3. Arrows indicate the
positions of the 59NTR mutations present in the cell culture-adapted HM175/
P16 virus.
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amplifying a similar 0.58-kb fragment from pLUC-P16-CAT with the mutagenic
sense primer 59-CAGCCCAAGCTTCAAGAGGGGTCTCCGGGA-39, which
lacks the HM175/P16 mutations at nt 0 and 8, and the antisense primer SLA-545.
The 0.35-kb HindIII-HpaI fragment of pLUC-WT-CAT was replaced with the
0.35-kb HindIII-HpaI fragment excised from the PCR-amplified product, which
contained HM175/P16 mutations at nt 152 and nt 203 and 204. p687 was created
by replacing the 1.3-kb NsiI-NotI fragment of pLUC-WT-CAT with the 1.3-kb
NsiI-NotI fragment from pLUC-P16-CAT, which contains only the nt 687 T-to-G
substitution. Finally, p152.203.687 was created by subcloning the 0.54-kb Hin-
dIII-NsiI fragment from p687 into the corresponding HindIII-NsiI sites of
p152.203.
To confirm the sequences of the manipulated regions within the bicistronic
plasmids listed above, plasmid DNAs were sequenced on a model 373A DNA
Sequencer (Applied Biosystems), using the Taq DyeDeoxy terminator cycle
sequencing kit (Applied Biosystems).
Recombinant retrovirus vector expressing T7 polymerase. To produce a T7
RNA polymerase retrovirus expression vector, a 2.7-kb fragment representing
the T7 RNA polymerase gene flanked by EcoRI and BamHI sites was amplified
by PCR from pOS2 (43) with the sense primer 59-TGAAGAGGGAATTCAT
GAACACGATTAACATCGCT-39 and the antisense primer 59-TTAGTGCA
GGATCCTTACGCGAACGCGAAGTCCGAC-59. The product was digested
with EcoRI and BamHI, and the resulting fragment was inserted into the mul-
tiple cloning site of the Moloney murine leukemia virus plasmid pLXSN (32) to
create pLXSN-T7 (Fig. 2). To obtain packaged virus, pLXSN-T7 was transfected
into the PA317 packaging cell line as described by Miller and Rosman (32).
Replication-incompetent LXSN-T7 virus was recovered in the supernatant 3
days posttransfection.
Cells. To produce the T7 RNA polymerase-expressing cell lines FRhK-T7 and
Huh-T7, FRhK-4 cells and Huh7 cells were infected with the LXSN-T7 virus
(multiplicity of infection of ;0.001) in the presence of 8 mg of Polybrene per ml.
After 2 h, virus-containing medium was replaced by growth medium (modified
Eagle’s medium supplemented with 10% fetal bovine serum, essential and non-
essential amino acids, and penicillin-streptomycin). Following an additional 48-h
incubation, cells were split 1:10 and 1:30 and fed with growth medium supple-
mented with 400 mg of Geneticin (active compound) per ml. After 7 days,
Geneticin-resistant colonies were clonally isolated and screened for the ability to
express CAT following transient transfection with pEMCV-CAT DNA (43).
DNA transfections and reporter gene assays. DNA transfections were carried
out in six-well culture plates as described previously (43), but with 1 mg of
plasmid DNA and 15 ml of Lipofectin (Gibco BRL) per well. For transfections
of Huh-T7 cells, the cells were infected with recombinant vaccinia virus, vTF7-3
(18), expressing T7 RNA polymerase (multiplicity of infection of 10) 1 h prior to
DNA transfections (see Results). At 20 to 24 h following transfection, cells were
washed with phosphate-buffered saline, and 1 ml of TEN buffer (10 mM Tris-
HCl [pH 8.0], 1 mM EDTA, 100 mM NaCl) was added to each well. After 10
min, cells were mechanically removed from the plastic surface, and the resulting
cell suspension was divided into 750- and 250-ml aliquots for CAT and luciferase
assays. For the CAT assays, cells were pelleted, resuspended in 75 ml of 0.25 M
Tris-HCl (pH 8.0), and lysed by freeze-thawing. CAT activity in the cell lysates
was determined by a phase extraction assay which quantitates butyrylated
[14C]chloramphenicol products by liquid scintillation counting following xylene
extraction (pCAT reporter gene systems; Promega) (43). To quantitate lucif-
erase activity, cells were lysed in 13 cell culture lysis buffer (luciferase assay
system E1500; Promega). Lysates (20 ml) were incubated with 100 ml of luciferin
substrate (Promega), and luminescence was measured with a BioOrbit 1250
luminometer (LKB-Wallac, Turku, Finland) (43). For most experiments, CAT
expression is reported as the activity present in 50 ml of extract, and luciferase
expression is reported as the activity in 20 ml of extract (both levels corrected for
background values in mock-transfected cells). However, where noted, both en-
zyme levels were normalized to protein content of these cell lysates, determined
by a Coomassie blue assay (Bio-Rad).
RNase protection assays. An RNase protection assay for quantitation of RNA
transcripts containing the CAT coding sequence was developed by using rea-
gents and protocols from a lysate RNase protection assay kit (United States
Biochemical Company). RNA probes included a 0.22-kb 32P-labeled antisense
CAT probe transcribed from SspI-linearized pHAV-CAT DNA with SP6 poly-
merase and a 0.14-kb 32P-labeled human glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) antisense probe transcribed from a GAPDH control template
(United States Biochemical) with T7 RNA polymerase. This latter probe was
included to monitor the amount of total cellular RNA in each lysate. In the
RNase protection assay, the antisense probes were designed to produce pro-
tected fragments of 0.21 and 0.10 kb, respectively. Transfected cells were washed
and lysed with 1 ml of 4 M guanidine thiocyanate–25 mM sodium citrate–0.5%
sarcosyl. The resulting cell lysates were hybridized with a mixture of the 32P-
labeled antisense RNA probes for 12 h at 378C and then diluted and extensively
digested with RNases and proteinase K. Protected RNA fragments were precip-
itated with isopropanol and electrophoresed on a 6% denaturing polyacrylamide
gel. Bands representing the protected fragments of the CAT and GAPDH
probes were detected by autoradiography, and their relative intensities were
quantitated on a Hoefer Scientific GS 300 densitometer.
RESULTS
Monkey kidney cell lines which stably express cytoplasmic
bacteriophage T7 RNA polymerase.Mutations which occurred
within the 59NTR of HM175/P16 virus during its passage in
cultured African green monkey kidney cells promote the
growth of this virus in these (i.e., BS-C-1) cells but not in
cultured fetal rhesus kidney (FRhK-4) cells, which are also
permissive for HAV (11). Two of three implicated mutations
map within the IRES of HAV (at nt 203 and 687), while the
third mutation which might be involved in growth enhance-
ment (at nt 152) is located upstream of this translational con-
trol element (6). To determine whether these mutations act to
enhance replication by facilitating IRES-directed translation in
a cell-type-specific fashion, we transformed and selected stable
lines of cells which constitutively express bacteriophage T7
RNA polymerase from both the BS-C-1 and FRhK-4 cell lin-
eages. The T7 polymerase expressed in the cytoplasm of these
new cell lines, BT7-H and FRhK-T7, directs the transcription
of RNA following the transfection of these cells with plasmid
DNA containing T7 transcriptional units. Because these cyto-
plasmic RNA transcripts lack a 59 m7G cap structure, their
efficient translation is dependent on the inclusion of an IRES
element within the transcript (13, 43).
The BT7-H cell line has been described previously (43). It
has provided a useful system for evaluating the relatively weak
translational activity of the HAV IRES when this RNA struc-
ture is placed within the context of either monocistronic or
bicistronic transcripts (43). To develop a companion T7-ex-
pressing cell line derived from FRhK-4 cells, we used a murine
Moloney leukemia virus-based vector (32). FRhK-4 cells were
infected with the recombinant replication-defective retrovirus
LXSN-T7, which contains the coding sequence for bacterio-
phage T7 RNA polymerase under control of the retroviral long
terminal repeat in addition to a selectable marker gene (neo)
(Fig. 2). Stably transformed cells were clonally selected in the
presence of Geneticin. Each of the Geneticin-resistant clones
that were tested supported transcription from the T7 pro-
moter, as demonstrated by the expression of CAT following
transfection with pEMCV-CAT, which contains a T7 transcrip-
tional unit with the EMCV IRES fused to the CAT coding
sequence (data not shown). The clone producing the greatest
CAT expression was designated FRhK-T7 and used for all
subsequent experiments.
Analysis of IRES-directed translation in BT7-H and
FRhK-T7 cell lines. To compare the abilities of BT7-H and
FRhK-T7 cells to support IRES-dependent translation, we
constructed several plasmids containing bicistronic T7 tran-
scriptional units of the form luciferase-picornavirus 59NTR-
CAT (Fig. 3A). The upstream cistron (luciferase) within the
uncapped bicistronic RNAs produced by these plasmids in
cells expressing T7 polymerase is translated with very low ef-
ficiency by a 59-end-dependent scanning mechanism (27, 43).
Translation of the downstream cistron (CAT) is dependent on
the presence of an IRES in the intercistronic space. Thus,
while luciferase expression reflects both the efficiency of trans-
fection and T7 transcription, the level of CAT activity relative
to luciferase activity expressed in transfected cells reflects the
FIG. 2. Schematic diagram of the murine retrovirus vector pLXSN-T7. LTR,
long terminal repeat; SV, SV40 early promoter, NEO, neomycin phosphotrans-
ferase gene (selectable marker); pA, polyadenylation site. Arrows depict tran-
scriptional start sites.
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translation-initiating activity of the IRES (43). Using a lipo-
some-mediated transfection protocol, BT7-H, FRhK-T7, and
normal FRhK-4 cells were transfected with several plasmid
DNAs: pLUC-EMCV-CAT (which contains nt 280 to 836 of
the 59NTR of EMCV in the intercistronic space), pLUC-SAB-
CAT (containing the entire 59NTR of Sabin poliovirus type 1),
pLUC-P16-CAT (containing the 59NTR of the cell culture-
adapted HAV, HM175/P16), and pLUC-D355-532-CAT (which
contains this HAV 59NTR with a large internal deletion which
abolishes IRES-directed translation in BT7-H cells and rabbit
reticulocyte lysates) (43) (Fig. 3A). CAT and luciferase activ-
ities were measured in cell lysates prepared 20 h following
transfection (Fig. 3B). As expected, significant reporter gene
expression from these plasmids was found only in transfected
BT7-H and FRhK-T7 cells, indicating that expression was de-
pendent on T7 RNA polymerase, as demonstrated previously
for BT7-H cells (43).
Significant differences were noted in the translational activ-
ities of the three picornaviral IRES elements included in the
experiment shown in Fig. 3B. CAT expression from pLUC-
EMCV-CAT transcripts was high in both BT7-H (mean 5
91,700 cpm/mg of protein) and FRhK-T7 (38,500 cpm/mg of
protein) cell lysates, as expected from previous experiments
which demonstrated high translational activity of the monocis-
tronic plasmid, pEMCV-CAT, in BT7-H cells (43). CAT ex-
pression from pLUC-SAB-CAT was considerably lower in ei-
ther BT7-H (55,200 cpm/mg of protein) or FRhK-T7 (10,100
cpm/mg of protein) cells, suggesting that the IRES of Sabin
type 1 poliovirus is about one-half to one-fourth as active as
that of EMCV in these cell lines. In contrast, CAT was ex-
pressed with much lower efficiency from pLUC-P16-CAT in
both BT7-H (822 cpm/mg of protein) and FRhK-T7 (237
cpm/mg of protein) cells. Nonetheless, HAV-directed CAT
expression was clearly measurable in comparison with CAT
activity present following mock (48.2 cpm/mg of protein) or
pLUC-D355-532-CAT (35.4 cpm/mg of protein) transfection of
these cells (results are for BT7-H cells) (Fig. 3B). These results
are consistent with the very low activity of the HAV IRES
which we have previously noted (43) but provide for the first
time a direct comparison of HAV and poliovirus IRES activ-
ities in vivo. With each plasmid tested, CAT expression was
approximately two- to threefold higher in BT7-H than in
FRhK-T7 cells, possibly reflecting differences in the efficiency
of DNA transfection or the level of endogenous T7 polymerase
activity in the two cell lines.
Interestingly, luciferase expression varied in an inverse fash-
ion with CAT expression when plasmid DNAs containing
IRES elements of widely varying activities were transfected
into these cells (Fig. 3B). We have shown previously that ex-
pression of the upstream cistron, luciferase, in transfected
BT7-H cells is due to a cap-independent mechanism and not
related to cryptic nuclear synthesis of capped RNA transcripts
(43). The ability to detect this very inefficient translation of
uncapped transcripts which lack an IRES reflects the abun-
dance of the T7 transcripts and the use of very sensitive re-
porter systems. In the experiment shown in Fig. 3B, luciferase
expression was greatest from pLUC-D355-532-CAT, which
lacks a functional IRES, followed by pLUC-P16-CAT and
pLUC-SAB-CAT. The lowest level of expression of luciferase
was with pLUC-EMCV-CAT. These results suggest that there
is competition between the two cistrons for necessary cellular
translation factors and that competition from the IRES ele-
ment is related to its activity in promoting internal initiation of
translation. We have noted similar effects in rabbit reticulocyte
lysates programmed with bicistronic RNA transcripts (6).
To confirm that the differences in the levels of CAT and
luciferase expression observed following transfection of BT7-H
and FRhK-T7 cells were not due to differences in transfection
or T7 transcriptional efficiency with individual plasmids, or in
the stability of the transcripts, we examined the relative abun-
dance of CAT transcripts in transfected cells by an RNase
protection assay (Fig. 4). This assay used a mixture of an
anti-sense RNA probe which hybridizes to CAT sequence
within the RNA transcripts and a probe which hybridizes to
cellular GAPDH mRNA. The second probe was included to
monitor total cellular RNA levels in each lysate. A protected
RNA fragment representing the expected size of the protected
antisense CAT probe was present in each transfected cell ly-
sate (Fig. 4). Quantitation of CAT and GAPDH protected
fragments demonstrated that CAT/GAPDH ratios varied min-
imally in the plasmid transfections of both the BT7-H (0.149 to
0.197) and the FRhK-T7 (0.143 to 0.171) cells (data not
shown). Thus, differences in the levels of CAT and luciferase
activities in BT7-H and FRhK-T7 cells transfected with differ-
ent bicistronic plasmids (Fig. 3B) reflect differences in the
efficiency of IRES-directed translation and not differences in
the abundance of RNA transcripts.
Comparison of IRES-directed translation from HM175/wt
and HM175/P16 5*NTRs in monkey kidney cells. Since HAV
translation can be monitored readily in both BT7-H and
FRhK-T7 cells, it was possible to compare translation initiated
by internal entry from the 59NTR of the attenuated cell cul-
ture-adapted variant HM175/P16 with translation initiated
from the wild-type 59NTR in these cell types. For this analysis,
we constructed an additional bicistronic plasmid, pLUC-WT-
CAT, which contains the 59NTR of HM175/wt virus within its
intercistronic space (Fig. 5A). The expression of CAT and
luciferase in a typical experiment in which BT7-H and FRhK-
T7 cells were transfected with pLUC-P16-CAT or pLUC-WT-
CAT is shown in Fig. 5B. Transfections were carried out in
triplicate. In BT7-H cells, the ratio of CAT activity to lucif-
erase activity was 5.1-fold greater from pLUC-P16-CAT
(10,700 cpm/light unit, 6 SEM [standard error of the mean]
245) than from pLUC-WT-CAT (2,110 cpm/light unit, 6 SEM
288). In contrast, CAT/luciferase ratios were similar in FRhK-T7
cells transfected with either pLUC-P16-CAT or pLUC-WT-
FIG. 3. Translation of bicistronic transcripts in BT7-H, FRhK-T7, and nor-
mal FRhK-4 cells. (A) Organization of T7 transcripts of the form luciferase-
59NTR-CAT which are expressed in the T7 cell lines following transfection with
plasmid DNA. (B) CAT and luciferase (Luc) activities, each normalized to
protein content, present in lysates of monkey kidney cells prepared 20 h after
transfection with pLUC-EMCV-CAT (bar a), pLUC-SAB-CAT (bar b), pLUC-
P16-CAT (bar c), pLUC-D355-532-CAT (bar d), or no plasmid (mock transfec-
tion; bar e). Results shown are means of duplicate transfections 6 range.
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CAT (3,540 cpm/light unit or 3,910 cpm/light unit). The CAT/
luciferase ratio should be a good measure of IRES activity over
a wide range of transcript levels. However, to confirm that the
expression of CAT and luciferase was not influenced by dif-
ferences in T7 transcript levels, RNase protection assays were
carried out as described above and demonstrated that tran-
script levels did not vary significantly following transfections in
either the BT7-H or FRhK-T7 cells (data not shown). Although
the magnitude of differences in the CAT/luciferase ratios
might be exaggerated by intercistronic competition in compar-
isons of IRES elements which are widely different in their
activities (such as the HAV and EMCV IRES elements; Fig.
3B), the modest difference observed in HM175/wt and HM175/
P16 IRES activities did not appear to significantly affect trans-
lation of the upstream luciferase cistron (Fig. 5B). The data
shown in Fig. 5 thus indicate that the translational effects of the
59NTR mutations in HM175/P16 virus mimic their cell-type-
specific effects on viral replication (11).
To determine which individual mutation(s) are responsible
for this translational enhancement in BT7-H cells, we con-
structed a series of bicistronic plasmids containing the wild-
type 59NTR with various combinations of the HM175/P16 mu-
tations at positions 152, 203 and 204, and 687 (Fig. 6A). These
are the mutations which previous results indicate are respon-
sible for enhanced replication in BS-C-1 cells (11). The bicis-
tronic plasmids were transfected into BT7-H cells, and CAT
and luciferase activities were measured as before (Fig. 6B).
Consistent with the results shown in Fig. 5B, the CAT/lucif-
erase ratios were 2,100 cpm/light unit, 6 SEM 300, for pLUC-
WT-CAT and 10,100 cpm/light unit, 6 SEM 320, for pLUC-
P16-CAT. The CAT/luciferase ratio following transfection of
plasmid p152 was similar to that for pLUC-WT-CAT, indicat-
ing that the A-to-G substitution at nt 152 does not have an
enhancing effect on translation. In contrast, p203, containing a
UU deletion at nt 203 and 204, and p687, containing a U-to-G
substitution at nt 687, both produced approximately 3.5-fold
increases in the CAT/luciferase ratio (6,930 cpm/light unit, 6
SEM 610, and 6,710 cpm/light unit, 6 SEM 720), compared
with that observed with pLUC-WT-CAT (Fig. 6B). In cells
transfected with p152.203.687, which contains both the nt 203-
204 and 687 mutations as well as the substitution at nt 152, the
CAT/luciferase ratio (10,900 cpm/light unit, 6 SEM 460) was
nearly identical to that for pLUC-P16-CAT, which contains all
five of the HM175/P16 59NTR mutations (Fig. 6A).
To confirm that the nt 203-204 and 687 mutations had no
effect on IRES-dependent translation in fetal rhesus monkey
kidney cells, we transfected the same series of bicistronic plas-
mids into FRhK-T7 cells (Fig. 7). As expected from the results
shown in Fig. 5B, CAT/luciferase ratios did not vary signifi-
cantly with the bicistronic plasmids containing different com-
binations of the HM175/P16 mutations. These results further
demonstrate that the HM175/P16 mutations do not enhance
IRES-directed translation in fetal rhesus kidney cells.
Comparison of HM175/wt and HM175/P16 IRES-directed
translation in a human liver cell line. The Huh7 cell line is
derived from a human hepatocellular carcinoma and is per-
missive for HAV replication (data not shown). To assess the
effects of the 59NTR mutations on viral translation in these
cells, we established a stably transformed subline, Huh-T7,
which constitutively expresses T7 RNA polymerase. However,
the levels of T7 transcription and/or the efficiency of transla-
tion of bicistronic transcripts containing the EMCV or HAV
59NTR were low in these cells, resulting in only very low lev-
els of CAT and luciferase expressed following transfection with
either pLUC-EMCV-CAT or pLUC-P16-CAT (data not
shown). To enhance this level of expression, we infected the
Huh-T7 cells with recombinant vaccinia virus vTF7-3 immedi-
ately prior to DNA transfections. While this is likely to result
in the presence of a 59 cap structure in a small proportion of
the T7 transcripts (17), it should not affect internally initiated
translation from bicistronic transcripts. CAT and luciferase
expression following transfection with pLUC-WT-CAT or
pLUC-P16-CAT in vTF7-3 infected Huh-T7 cells is shown in
Table 1. Although the absolute level of expression was much
higher than in the other T7-expressing cell lines which were not
infected with the recombinant vaccinia virus (Fig. 3), the CAT/
luciferase ratio was similar. Importantly, the CAT/luciferase
ratio following transfection with pLUC-WT-CAT (1,230 cpm/
light unit,6 SEM 63) was similar to that observed with pLUC-
P16-CAT (1,320 cpm/light unit,6 SEM 62). These values were
much less than the CAT/luciferase ratio following transfection
of the positive control pLUC-EMCV-CAT (35,100 cpm/light
unit, 6 SEM 3,400). These results strongly suggest that the
HM175/P16 mutations do not enhance or reduce IRES-di-
rected translation in this cell type.
DISCUSSION
Mutations responsible for the adaptation of HAV to effi-
cient growth in cultured cells have been mapped to the 59NTR
as well as the P2 region of the genome, within the sequence
encoding the 2B and 2C proteins (11, 14). A mutation at nt
3889, which results in an alanine-to-valine substitution within
the 2B protein, appears to be particularly important in deter-
FIG. 4. Quantitation of RNA transcripts in transfected BT7-H and FRhK-T7
cells by RNase protection assay. Cells were harvested 20 h posttransfection, and
lysates were hybridized overnight with 32P-labeled antisense RNA probes com-
plementary to CAT and GAPDH coding sequences. Following digestion with
RNases and proteinase K, samples were electrophoresed on a 6% denaturing
polyacrylamide gel. Lane 1, antisense RNA probes; lanes 2 to 11, protected RNA
from BT7-H (lanes 2 to 6) and FRhK-T7 (lanes 7 to 11) cells. Cells were
transfected with no DNA (lanes 2 and 7), pLUC-EMCV-CAT (lanes 3 and 8),
pLUC-SAB-CAT (lanes 4 and 9), pLUC-P16-CAT (lanes 5 to 10), or pLUC-
D355-532-CAT (lanes 6 to 11). Open arrowheads indicate CAT and GAPDH
probes; solid arrowheads indicate protected CAT and GAPDH RNA fragments.
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mining this host range change (15). Although not proven, it is
likely that mutations in the P2 region act to enhance replica-
tion of the viral RNA in cultured cells. Within the 59NTR,
previous studies have shown that an A-to-G substitution at nt
152 and/or the deletion of two U residues at nt 203 and 204
substantially enhance viral replication in a cell-type-specific
fashion (11). Compared with a chimeric virus containing the
59NTR of HM175/wt, viruses containing these mutations rep-
licate substantially more efficiently in BS-C-1 cells (which are
derived from adult African green monkey kidney). In contrast,
there is no difference in the replication of these viruses in
FRhK-4 cells (which are of fetal rhesus kidney origin). In
addition to the mutations at nt 152 and 203, a U-to-G substi-
tution at nt 687 has also been shown to enhance viral replica-
tion in BS-C-1 cells (10, 11).
Both the nt 152 and the nt 203-204 mutations are found in
the cell culture-adapted HM175/P16 and the HM175/P35 vi-
ruses, although the HM175/P35 virus contains only a single U
deletion at base 203 (9, 25). The U deletion at base 203 is also
found in a third cell culture-adapted variant of this strain of
HAV, HM175/P59, that was independently isolated in African
green monkey kidney cells (36). The nt 687 mutation is present
in both the HM175/P16 and HM175/P59 viruses and in cell
culture-adapted variants of HAV strain GBM (9, 21, 36). Al-
though it is not present in HM175/P35 virus, subsequent ad-
aptation of this virus to growth in human diploid (MRC-5)
cells resulted in the appearance of the nt 687 mutation, in
addition to others within the IRES (19). The presence of the
mutations at nt 203 and 687 in each of three independently
isolated cell culture-adapted HAV variants suggests that they
play a role in allowing the virus to overcome a restriction to
growth which is normally present in cultured African green
monkey kidney cells. Here, we have shown that this restriction
is related to viral translation.
We examined translation directed by the HAV IRES in two
monkey kidney cell lines, BT7-H and FRhK-T7, both of which
constitutively express T7 RNA polymerase. Following trans-
fection of these cells with plasmid DNAs containing bicistronic
T7 transcriptional units of the general form luciferase-59NTR-
CAT, the efficiency of internally initiated translation was esti-
mated by comparing levels of CAT and luciferase activities
present in cell lysates (43). Although in this study we examined
only translation directed by bicistronic transcripts, the BT7-H
and FRhK-4 cells offer a unique system for the evaluation of
IRES activities within the context of monocistronic RNAs be-
FIG. 5. Translation directed by bicistronic constructs containing either the HM175/wt or HM175/P16 59NTR in two T7 RNA polymerase-expressing monkey kidney
cell lines. (A) Schematic of pLUC-WT-CAT and pLUC-P16-CAT transcripts. (B) CAT and luciferase (Luc) activities present in BT7-H or FRhK-T7 lysates prepared
20 h after transfection with pLUC-WT-CAT or pLUC-P16-CAT. Results of triplicate transfections are presented as means 6 SEM. Calculated CAT/luciferase ratios
are shown at the bottom.
FIG. 6. (A) Schematic representation of T7 transcripts expressed from bicis-
tronic plasmids. pLUC-WT-CAT contains the HM175/wt 59NTR, and pLUC-
P16-CAT contains the HM175/P16 59NTR. Plasmids 2 to 6 contain the wild-type
59NTR with HM175/P16 mutation(s) at the positions indicated by triangles (see
Fig. 1). Luc, luciferase. (B) CAT and luciferase (Luc) activities 20 h after
transfection of BT7-H cells. Results shown are means of triplicate transfections
6 SEM. Calculated CAT/luciferase ratios are shown at the bottom.
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cause the T7 transcripts produced in these cells are not capped
and thus closely resemble picornaviral RNAs (43). Both
BT7-H and FRhK-T7 cells are derived from HAV-permissive
cell lines which are often used for propagation of this virus in
the laboratory.
We first compared the abilities of BT7-H and FRhK-T7 cells
to support translation from bicistronic transcripts containing
IRES elements derived from EMCV, the Sabin type 1 polio-
virus, and HAV. Since the EMCV IRES efficiently directs
cap-independent translation in a wide range of mammalian cell
types (12, 24), it was not surprising that we found bicistronic
RNAs containing the IRES of EMCV initiated translation in
both BT7-H and FRhK-T7 cells more efficiently than bicis-
tronic RNAs containing the poliovirus 59NTR and much more
efficiently than transcripts containing the HAV 59NTR (Fig.
3B). The very low activity of the HAV IRES was consistent
with our previous observation that the IRES in the cell culture-
adapted HM175/P16 virus is approximately 200-fold less effi-
cient than the EMCV IRES in directing translation from
monocistronic transcripts (43). In bicistronic transcripts pro-
duced in both BT7-H and FRhK-4 cells, we found the HAV
IRES in this study to be approximately 50-fold less efficient
than the poliovirus IRES and 100-fold less efficient than the
EMCV IRES (Fig. 3B).
When bicistronic transcripts containing IRES elements of
widely differing activities, such as the EMCV IRES and the
HAV IRES, were expressed in these cells, the efficiency with
which the upstream cistron, luciferase, was translated was in-
versely related to the efficiency of translation of the down-
stream cistron, CAT (Fig. 3B). Previous studies indicate that
translation of the upstream cistron in these T7 transcripts is
not due to the presence of a 59 cap structure, as it is enhanced
by coexpression of the 2A protease of poliovirus (43). The
intercistronic competition which is evident from the data
shown in Fig. 3 indicates that the translation of the upstream
cistron, which probably occurs by a 59-end-dependent scanning
mechanism, and the IRES-dependent translation of the down-
stream cistron utilize common cellular translation factors.
These data further suggest that T7 transcripts are present in
these cells at or near saturating levels with respect to transla-
tion.
A comparison of translation initiated from bicistronic RNAs
containing either the HM175/wt or the HM175/P16 59NTR
demonstrated that the mutations in HM175/P16 virus enhance
translation by internal entry in BT7-H cells (Fig. 5B). These
results support the hypothesis that these HM175/P16 muta-
tions enhance viral replication in BS-C-1 cells (11) by facilitat-
ing cap-independent, internal initiation of viral translation. As
with the effects of these mutations on viral growth, the en-
hancement of translation mediated by the HM175/P16 muta-
tions was highly host cell specific. The mutations had no effect
on viral translation in either FRhK-T7 cells (Fig. 5B and 7) or
Huh-T7 cells (Table 1) or in vitro in rabbit reticulocyte lysates
(11) (data not shown). The UU deletion at nt 203 and 204 and
the U-to-G substitution at nt 687 contributed additively to this
translational enhancement (Fig. 6B). These results are thus in
close agreement with previous studies which examined the
effect of these 59NTR mutations on viral replication (11).
The impact of these mutations on IRES-directed translation
provides additional support for the location of the HAV IRES
as determined in earlier deletion mutagenesis studies (6). We
previously mapped the 59 limits of the HAV IRES to stem-loop
IIIa (Fig. 1) (6), which includes the site of the UU deletion at
nt 203 and 204. The U-to-G substitution at nt 687 lies approx-
imately 50 nt upstream of the initiator AUGs and is also within
the mapped limits of the IRES. However, although enhance-
ment of viral replication via a secondary effect of the nt 203-
204 and 687 mutations on RNA replication would seem to be
a very remote possibility, it is worth noting that Borman et al.
(3) have suggested that the poliovirus IRES may contain sig-
nals necessary for RNA replication as well as translation. The
other mutations within the 59NTR of HM175/P16, which in-
clude the addition of a U at the extreme 59 end of the genome
and substitutions at nt 8 and 152 (Fig. 1), are located upstream
of the HAV IRES (6) and had no apparent effects on viral
translation in either of the monkey kidney cell types (Fig. 5B).
Nonetheless, the A-to-G substitution at nt 152 is present in at
least two independently isolated, cell culture-adapted strains,
suggesting that it may also play a role in cell culture adaptation.
If so, it is likely that this mutation has a primary effect on RNA
replication, since it is part of a single-stranded domain in which
deletion mutations (at nt 140 to 144) have been shown to result
in a temperature-sensitive RNA replication phenotype (38).
Studies examining this possibility are in progress.
The mechanism by which the UU deletion at nt 203 and 204
and the U-to-G substitution at nt 687 of the HAV 59NTR
enhance viral translation in a cell-type-specific fashion is un-
known. Both mutations likely alter the secondary structure of
the 59NTR only minimally. The UU deletion at nt 203 and 204
would shorten a UUUUU tract normally present in HM175/wt
virus, resulting in a reduction in an unpaired bulge loop near
the top of stem-loop IIIa (5, 37) (Fig. 1). The substitution at nt
687 would minimally destabilize a putative stem-loop structure
(stem-loop Vc) located just upstream of the initiator AUGs,
resulting in a change in free energy from 212.9 to 28.7 kcal (1
cal 5 4.184 J)/mol, according to energy values of Freier et al.
(16). Although minimal, our data indicate that these structural
changes affect the affinity of the IRES for essential cellular
translation initiation factors which thus far remain poorly de-
fined (24, 29, 30).
Using a UV cross-linking/label transfer assay, Chang et al.
(7) previously identified three ribosome-associated proteins
(p30, p39, and p110) that are present in both BS-C-1 and
FIG. 7. Translation of HAV bicistronic transcripts in FRhK-T7 cells. Results
shown are means of triplicate transfections 6 SEM. See the legend to Fig. 6 for
details.
TABLE 1. Translation mediated by the 59NTRs of HM175/wt and











pLUC-WT-CAT 5.38 6 0.51 4,370 6 280 1,230 6 63
pLUC-P16-CAT 5.88 6 0.44 4,460 6 160 1,320 6 62
pLUC-EMCV-CAT 84.6 6 4.1 2,410 6 300 35,100 6 3,400
a Huh7-T7 cells were infected with vTF7-3 (multiplicity of infection of 10)
prior to transfection with plasmid DNA (see Materials and Methods). Results
are means of duplicate transfections 6 SEM.
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FRhK-4 cells and which bind to specific domains within the
59NTR of HAV. While the binding of these proteins was not
specifically localized to the sites of the nt 203-204 and 687
mutations, a role for these nucleotides in determining the
binding affinity of these proteins cannot be excluded on the
basis of available data. However, it remains unknown whether
any of these proteins have a function related to HAV IRES-
mediated translation. Their role in the cell culture adaptation
of HM175/P16 virus is equally difficult to assess, since similar
proteins were identified by UV cross-linking/label transfer ex-
periments with extracts prepared from both BS-C-1 and
FRhK-4 cells despite the functional differences that we have
shown exist in HAV translation in these two cell types (7). It is
interesting, however, that UV cross-linking/label transfer stud-
ies carried out with extracts of a human cellular carcinoma cell
line, HepG2, identified an alternate set of ribosome-associated
proteins which resemble those previously identified in HeLa
cells (7, 8). These include the 57-kDa pyrimidine tract-binding
protein, which has been suggested to be an important cellular
factor involved in picornaviral translation initiation (2, 4, 21a,
24).
While we do not know which HAV RNA-binding proteins
are present in human liver, the results shown in Fig. 3 and 5
suggest that the cellular factors involved in IRES-directed
translation within the liver differ significantly from those
present in cultured African green monkey kidney cells. This
conclusion is consistent with the data shown in Table 1, which
indicate that the HM175/P16 mutations do not have a positive
impact on IRES-mediated translation in Huh-T7 cells, which
are derived from human hepatocytes. Viruses which contain
these 59NTR mutations are highly attenuated in otherwise
susceptible primates (26, 41). Although changes elsewhere in
the genome are likely to play an important role in attenuation
(15), it would be interesting to know the effects of these mu-
tations on translation within the liver.
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